Navigation Links
Ceragenix Announces Ceragenins Virtually Prevent Catheter Biofilm,Formation in 21 Day Study

DENVER--(BUSINESS WIRE)--Mar 12, 2007 - Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP), a biopharmaceutical company focused on infectious disease and dermatology, today announced that a catheter treated with a Ceragenin compound demonstrated virtually no biofilm formation in a 21 day study.

In the study, polyurethane catheters treated with Ceragenins were soaked daily in a phosphate-suffered solution along with an untreated catheter. At day 21, the catheters were challenged with an inoculum of one million colony forming units of methicillin-resistant staph aurius (MRSA). The untreated control catheter had 30,000 bacterial colony forming units (CFUs) adhered to the catheter surface while the Ceragenin treated catheters had fewer than 100 CFUs adhered to the surface.

"This study demonstrates the potential for Ceragenins to be utilized as an antimicrobial treatment for indwelling medical devices," said Steven S. Porter, Chairman and Chief Executive Officer. "The duration efficacy of the Ceragenin treatment is also very significant, given that currently available antimicrobial coatings and treatments are generally efficacious for only 7 to 10 days. While further development work is needed, we are very encouraged by the results of this study."

The results of this study will be included in a webcast presentation being given later today by Dr. Paul B. Savage of Brigham Young University. Dr. Savage is the inventor of the Ceragenin technology, which Ceragenix has exclusively licensed from Brigham Young University. The webcast information is as follows: -0-

Date & Time:  March 12, 2007 @ 1:00 PM Eastern Time


Webcast link for viewing presentation

http://www.vcall.com/IC/CEPage.asp?ID=114215


Participant Dial in: U.S. and Canada (Toll Free): 877-407-0782

Participant Dial in: International: 201-689-8567


The call will be available for replay at

http://www.investorcalendar.com/ClientPage.asp?
'"/>




Page: 1 2 3 

Related medicine technology :

1. Ceragenix Compound Shows Promise for Treating Lethal Cystic
Fibrosis Infections
2. Ceragenix Announces Results from Phase IV Study of EpiCeram Meet
All Primary and Secondary Endpoints
3. Ceragenix Announces New Publication of Scientific Research on
Ceragenin Technology
4. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
5. Neose Announces Presentation of Positive Preclinical Data on
GlycoPEGylated Factor VIIa at the XXI Congress of the International
Society on Thrombosis and Haemostasis
6. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy
of BF-200 ALA In Actinic Keratosis
7. YM BioSciences Announces Secondary Efficacy and Safety Findings in
Randomized Phase IIB Aerolef Trial
8. BioSante Pharmaceuticals Announces New Findings for Potential Bird
Flu Vaccine
9. Portola Pharmaceuticals Announces Positive Data from a Phase II
Study of its Factor Xa Inhibitor at the XXI Congress of the
International Society on Thrombosis and Haemostasis
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for
Oral Oleoyl-estrone
11. AVI BioPharma Partner Cook Medical Announces Completion of Patient
Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of
Cardiovascular Disease
Post Your Comments:
(Date:6/18/2013)... , June 18, 2013 Valeant Pharmaceuticals ... VRX) has priced its previously announced public offering of ... Company will issue 23,529,412 common shares at a price ... approximately $2.0 billion. The Company will file a final ... Form S-3 and will make a similar filing with ...
(Date:6/18/2013)...  Actavis, Inc. (NYSE: ACT ) today announced ... Securities and Exchange Commission (SEC) a registration statement on Form ... Chilcott plc (NASDAQ: WCRX ), which included ... (the "Form S-4"). As previously announced on ... entered into a definitive agreement pursuant to which Actavis will ...
(Date:6/18/2013)... 18, 2013 Royal Philips (NYSE: ... Overall Performance Leader in Imaging Equipment in the 2013 ... Philips also received Best in KLAS and Best in ... Core 128 Computed Tomography (CT), Ingenia 1.5T and ... cardiograph. The annual Best in KLAS Awards: Medical Imaging ...
Breaking Medicine Technology:Valeant Pharmaceuticals Prices Public Offering Of Common Shares 2Valeant Pharmaceuticals Prices Public Offering Of Common Shares 3Valeant Pharmaceuticals Prices Public Offering Of Common Shares 4Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 2Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 3Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 4Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 5Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 6Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 7Philips Named 2013 Overall Performance Leader In Imaging Equipment By KLAS 2
(Date:6/19/2013)... 2013 Dental professionals are increasingly monitoring ... minor to moderate sedation, a patient’s breathing depth and ... is the latest to update its guidelines to require ... in an effort to increase safety in procedures. This ... Act goes into effect July 1. , The ...
(Date:6/19/2013)... June 19, 2013 DiscountFurnaceFilter.com, the number one ... offer the 5-2-1 Compressor Saver kit at an exceptional price. ... Kit) aids the air conditioning unit during start up, saving ... air compressor or unit burn out. , The 5-2-1 ... the air conditioner uses less power to start and drastically ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Guests at the ... wealthy and wise even if they don’t go to bed ... require some early thought. , Crafty travelers ... they take advantage of the pet-friendly Scottsdale Paradise Valley hotel’s ... . With at least 14 days advance notice, guests can ...
(Date:6/19/2013)... Washington (PRWEB) June 19, 2013 ... physicians deem it medically necessary, according to a ... and Child Health Journal. The results of this ... for more than a decade – that trying-to-conceive ... and maintaining a healthy body weight. Fairhaven Health ...
(Date:6/19/2013)... The motor neuron disease Amyotrophic lateral sclerosis (ALS), also ... sequential pattern which can be classified into four distinct ... at the University of Pennsylvania in the Annals ... and spinal cord tissues shows, for the first time, ... starting point in the central nervous system to other ...
Breaking Medicine News(10 mins):Health News:Required Capnography Monitoring Growing Trend Among National and State Healthcare Organizations 2Health News:Required Capnography Monitoring Growing Trend Among National and State Healthcare Organizations 3Health News:Plan Ahead and Save Big With New Deal From Residence Inn Scottsdale Paradise Valley 2Health News:Plan Ahead and Save Big With New Deal From Residence Inn Scottsdale Paradise Valley 3Health News:Plan Ahead and Save Big With New Deal From Residence Inn Scottsdale Paradise Valley 4Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 2Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 3Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 4Health News:Staging system in ALS shows potential tracks of disease progression, Penn study finds 2
... dedicated to the health and well being of children, ... (FDA) has approved an investigational new drug application; ... topical solution for the treatment of head lice. ... professionals a new choice for the treatment of head ...
... cyclists will be participating in the Memory Ride for Alzheimer's ... to fight the disease that affects more than 5 ... 11th annual Memory Ride has a personal story to tell ... who has struggled with the disease. ,The Alzheimer's ...
... is not as squeaky-clean as she appears . ,In a ... she is quite the opposite of her supposed righteous image. ... Do you think you have a squeaky-clean image? Im like, Could ... Us Weekly quoted her, as telling the mag. ,I ...
... the University of Idaho is helping to increase understanding ... identify conditions that make women prone to infections and ... problems. ,Women suffer from insidious health problems, ... send them in droves to seek medical treatment, said ...
... the occurrence of anaphylaxis between the northern and southern ... be fatal without treatment with epinephrine. The striking ... risk, currently are without explanation. The investigators hypothesize, however, ... sunshine, may play a role and that this hypothesis ...
... can relieve people of shyness, and help them socialise with ... use, and an individual can boost self-confidence just by squirting ... that the spray harnesses the powers of a feel-good hormone ... in social recognition and bonding. ,The mammalian ...
Cached Medicine News:Health News:Vaginal Bacteria Vary Among Healthy Women 2Health News:Large Geographic Differences in EpiPen Prescriptions in the U. S. 2
It is designed for rigid skeletal fixation. These pins are constructed of stainless steel and can be removed for sterilization and reuse....
It is designed for rigid skeletal fixation. These pins are constructed of stainless steel and can be removed for sterilization and reuse....
It is designed for rigid skeletal fixation. These pins are constructed of stainless steel and can be removed for sterilization and reuse....
... designed for rigid skeletal fixation, ... freedom in positioning the fixation ... fixation is designed for the ... positions. Craniotomies can be performed ...
Medicine Products: